Featured Research

from universities, journals, and other organizations

Bladder cancer patients identified who could benefit from 'tumor-softening' treatment

Date:
July 30, 2014
Source:
Cancer Research UK
Summary:
A protein that could help doctors decide whichbladder cancerpatients would benefit from a treatment that makes radiotherapy more effective has been identified by researchers. The HIF-1-alpha protein indicates low oxygen levels in tumor cells -- a state known as 'hypoxia'. The CON treatment works by adding oxygen to the oxygen-deprived tumor cells which makes them more sensitive to the radiotherapy.

Scientists in Manchester have identified a protein that could help doctors decide which bladder cancer patients would benefit from a treatment that makes radiotherapy more effective, according to a study published in the British Journal of Cancer (BJC).

Related Articles


"This fascinating new finding could help doctors adapt their treatments to patients with bladder cancer," said Nell Barrie, Cancer Research UK

The team from The University of Manchester, funded by the Medical Research Council, found that patients whose bladder tumor had high levels of a protein, called 'HIF-1α', were more likely to benefit from having carbogen -- oxygen mixed with carbon dioxide gas -- and nicotinamide tablets at the same time as their radiotherapy. The treatment, called 'CON', makes radiotherapy more effective.

By comparing levels of HIF-1α in tissue samples from 137 patients who had radiotherapy on its own or with CON, the researchers found the protein predicted which patients benefited from having CON. High levels of the protein were linked to better survival from the disease when patients had radiotherapy and CON. Patients with low protein levels did not benefit from having CON with their radiotherapy.

The HIF-1α protein indicates low oxygen levels in tumor cells -- a state known as 'hypoxia'. The CON treatment works by adding oxygen to the oxygen-deprived tumor cells which makes them more sensitive to the radiotherapy.

Study author, Professor Catharine West, a Cancer Research UK scientist at The University of Manchester, said: "Although we have another biomarker that can predict responsiveness to CON and radiotherapy in bladder cancer patients, our findings tell us a bit more about the characteristics of bladder cancer tumors and how they may respond to this treatment."

"But we desperately need to do more work to find ways to treat those patients who won't see as much benefit from this.

"And it's exactly this type of vital research that we and other scientists will be doing at the Manchester Cancer Research Centre -- bringing together a wide range of expertise to revolutionise cancer treatment."

Around 65 people are diagnosed with bladder cancer in Manchester every year. There are around 25 deaths from the disease every year.

Nell Barrie, senior science communications manager at Cancer Research UK, said: "This fascinating new finding could help doctors adapt their treatments to patients with bladder cancer as well as shedding more light on the disease.

"Deaths from bladder cancer are falling in the UK, but more work needs to be done so that this trend continues. More research is needed to helps us find new and better ways to fight bladder cancer."


Story Source:

The above story is based on materials provided by Cancer Research UK. Note: Materials may be edited for content and length.


Journal Reference:

  1. B A Hunter, A Eustace, J J Irlam, H R Valentine, H Denley, K K Oguejiofor, R Swindell, P J Hoskin, A Choudhury, C M West. Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer. British Journal of Cancer, 2014; 111 (3): 437 DOI: 10.1038/bjc.2014.315

Cite This Page:

Cancer Research UK. "Bladder cancer patients identified who could benefit from 'tumor-softening' treatment." ScienceDaily. ScienceDaily, 30 July 2014. <www.sciencedaily.com/releases/2014/07/140730120154.htm>.
Cancer Research UK. (2014, July 30). Bladder cancer patients identified who could benefit from 'tumor-softening' treatment. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2014/07/140730120154.htm
Cancer Research UK. "Bladder cancer patients identified who could benefit from 'tumor-softening' treatment." ScienceDaily. www.sciencedaily.com/releases/2014/07/140730120154.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins